Clover Health Investments, Corp. /DE SEC filings CLOV

Clover Health Investments, Corp. /DE has 708 filings in SEC EDGAR's recent list, going back to Jan 31, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.

Clover Health Investments, Corp. /DE SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Officer or director change
Nov 4, 2026 Nov 2, 2026
4 Insider transaction Oct 20, 2026 Oct 20, 2026
4 Insider transaction Oct 20, 2026 Oct 19, 2026
144 Notice of proposed sale Oct 20, 2026 —
4 Insider transaction Oct 19, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 19, 2026 —
4 Insider transaction Oct 19, 2026 Oct 15, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 15, 2026 —
144 Notice of proposed sale Oct 15, 2026 —
144 Notice of proposed sale Oct 15, 2026 —
144 Notice of proposed sale Oct 15, 2026 —
144 Notice of proposed sale Oct 15, 2026 —
8-K Current report
Regulation FD disclosure
Oct 9, 2026 Oct 8, 2026
4 Insider transaction Oct 7, 2026 Oct 7, 2026
144 Notice of proposed sale Oct 7, 2026 —
4 Insider transaction Oct 5, 2026 Oct 5, 2026
144 Notice of proposed sale Oct 5, 2026 —
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Oct 1, 2026
3 Initial insider ownership Oct 1, 2026 Sep 22, 2026
3 Initial insider ownership Oct 1, 2026 Sep 22, 2026
144 Notice of proposed sale Oct 1, 2026 —
8-K/A Amended current report
Officer or director change
Sep 25, 2026 Sep 22, 2026
8-K Current report
Officer or director change
Sep 24, 2026 Sep 22, 2026
144 Notice of proposed sale Sep 24, 2026 —
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 17, 2026 Sep 16, 2026
144 Notice of proposed sale Sep 17, 2026 —
144 Notice of proposed sale Sep 16, 2026 —
4 Insider transaction Sep 16, 2026 Sep 15, 2026
4 Insider transaction Sep 15, 2026 Sep 15, 2026
4 Insider transaction Sep 15, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
4 Insider transaction Sep 14, 2026 Sep 14, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Aug 31, 2026 —
8-K Current report
Regulation FD disclosure
Aug 20, 2026 Aug 20, 2026
4 Insider transaction Aug 17, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 17, 2026 —
144 Notice of proposed sale Aug 14, 2026 —
4 Insider transaction Aug 13, 2026 Aug 12, 2026
4 Insider transaction Aug 13, 2026 Aug 12, 2026
4 Insider transaction Aug 10, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 10, 2026 —
144 Notice of proposed sale Aug 7, 2026 —
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jul 20, 2026 Jul 20, 2026
144 Notice of proposed sale Jul 20, 2026 —
4 Insider transaction Jul 17, 2026 Jul 17, 2026
144 Notice of proposed sale Jul 17, 2026 —
8-K Current report
Other events
Jul 17, 2026 Jul 4, 2026
4 Insider transaction Jul 16, 2026 Jul 15, 2026
4 Insider transaction Jul 16, 2026 Jul 15, 2026
4 Insider transaction Jul 16, 2026 Jul 15, 2026
4 Insider transaction Jul 16, 2026 Jul 15, 2026
4 Insider transaction Jul 16, 2026 Jul 15, 2026
144 Notice of proposed sale Jul 15, 2026 —
144 Notice of proposed sale Jul 15, 2026 —
144 Notice of proposed sale Jul 15, 2026 —
144 Notice of proposed sale Jul 15, 2026 —
144 Notice of proposed sale Jul 15, 2026 —
4 Insider transaction Jul 9, 2026 Jul 8, 2026
144 Notice of proposed sale Jul 8, 2026 —
4 Insider transaction Jul 6, 2026 Jul 3, 2026
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jul 1, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
8-K Current report
Other events
Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
144 Notice of proposed sale Jun 17, 2026 —
4 Insider transaction Jun 17, 2026 Jun 16, 2026
144 Notice of proposed sale Jun 16, 2026 —
8-K Current report
Officer or director change
Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 11, 2026
144 Notice of proposed sale Jun 11, 2026 —
8-K Current report
Other events
Jun 10, 2026 Jun 9, 2026
4 Insider transaction May 28, 2026 May 28, 2026
144 Notice of proposed sale May 28, 2026 —
4 Insider transaction May 19, 2026 May 18, 2026
4 Insider transaction May 18, 2026 May 16, 2026
144 Notice of proposed sale May 18, 2026 —
8-K Current report
Regulation FD disclosure
May 18, 2026 May 18, 2026
144 Notice of proposed sale May 14, 2026 —
4 Insider transaction May 13, 2026 May 13, 2026
144 Notice of proposed sale May 13, 2026 —
4 Insider transaction May 12, 2026 May 8, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Apr 28, 2026
4 Insider transaction Apr 21, 2026 Apr 18, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
3 Initial insider ownership Apr 9, 2026 Mar 30, 2026
3/A Form 3/a Apr 9, 2026 Mar 30, 2026
3 Initial insider ownership Apr 9, 2026 Mar 30, 2026
4 Insider transaction Apr 7, 2026 Apr 3, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
8-K Current report
Officer or director change, Other events
Apr 1, 2026 Mar 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 18, 2026 Mar 18, 2026
144 Notice of proposed sale Mar 18, 2026 —
4 Insider transaction Mar 17, 2026 Mar 14, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 14, 2026
S-8 Employee stock plan registration Mar 10, 2026 —
8-K/A Amended current report
Regulation FD disclosure
Mar 6, 2026 Mar 6, 2026
8-K Current report
Regulation FD disclosure
Mar 6, 2026 Mar 6, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 4, 2026 —
10-K Annual report Feb 27, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Feb 18, 2026 Feb 14, 2026
4 Insider transaction Feb 10, 2026 Feb 8, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
144 Notice of proposed sale Jan 20, 2026 —
8-K Current report
Regulation FD disclosure
Jan 14, 2026 Jan 14, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 7, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 7, 2026 —
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 3, 2026
4 Insider transaction Dec 18, 2025 Dec 18, 2025
144 Notice of proposed sale Dec 18, 2025 —
4 Insider transaction Dec 16, 2025 Dec 14, 2025
4 Insider transaction Dec 16, 2025 Dec 14, 2025
4 Insider transaction Dec 16, 2025 Dec 15, 2025
8-K Current report
Regulation FD disclosure
Dec 10, 2025 Dec 10, 2025
4 Insider transaction Nov 18, 2025 Nov 14, 2025
4 Insider transaction Nov 12, 2025 Nov 8, 2025
8-K Current report
Regulation FD disclosure
Nov 12, 2025 Nov 12, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
4 Insider transaction Nov 5, 2025 Nov 4, 2025
4 Insider transaction Nov 4, 2025 Oct 31, 2025
4 Insider transaction Nov 4, 2025 Oct 31, 2025
4 Insider transaction Nov 4, 2025 Oct 31, 2025
4 Insider transaction Nov 4, 2025 Oct 31, 2025
144 Notice of proposed sale Nov 4, 2025 —
8-K Current report
Regulation FD disclosure
Nov 4, 2025 Nov 4, 2025
4 Insider transaction Oct 31, 2025 Oct 29, 2025
8-K Current report
Officer or director change
Oct 31, 2025 Oct 31, 2025
4 Insider transaction Oct 21, 2025 Oct 17, 2025
4 Insider transaction Oct 21, 2025 Oct 18, 2025
4 Insider transaction Oct 17, 2025 Oct 15, 2025
4 Insider transaction Oct 17, 2025 Oct 15, 2025
4 Insider transaction Oct 17, 2025 Oct 15, 2025
4 Insider transaction Oct 17, 2025 Oct 15, 2025
4 Insider transaction Oct 17, 2025 Oct 15, 2025
144 Notice of proposed sale Oct 17, 2025 —
8-K Current report
Regulation FD disclosure
Oct 9, 2025 Oct 9, 2025
4 Insider transaction Oct 7, 2025 Oct 3, 2025
144 Notice of proposed sale Oct 7, 2025 —
4 Insider transaction Oct 3, 2025 Oct 1, 2025
4 Insider transaction Sep 19, 2025 Sep 17, 2025
4 Insider transaction Sep 17, 2025 Sep 15, 2025
144 Notice of proposed sale Sep 17, 2025 —
4 Insider transaction Sep 16, 2025 Sep 14, 2025
4/A Form 4/a Sep 16, 2025 Jun 30, 2025
4/A Form 4/a Sep 16, 2025 Sep 13, 2024
4/A Form 4/a Sep 16, 2025 Jun 30, 2024
4 Insider transaction Sep 16, 2025 Sep 14, 2025
4 Insider transaction Aug 18, 2025 Aug 14, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025
8-K Current report
Regulation FD disclosure
Aug 11, 2025 Aug 11, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
4 Insider transaction Aug 6, 2025 Aug 4, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Hospital & Medical Service Plans (SIC 6324)
Listed as
CLOV (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Jersey City, NJ
SEC filer status
Large accelerated filer
SEC CIK
1801170
Former names
Social Capital Hedosophia Holdings Corp. III (until Jan 7, 2021)

Other Hospital & Medical Service Plans companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.